Ifp Advisors, Inc Reata Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$30.85 - $93.17 $647 - $1,956	-21 Reduced 6.54%	300 $27,000
Q4 2022 Feb 07, 2023	SELL	$22.15 - $42.11 $2,259 - $4,295	-102 Reduced 24.11%	321 $12,000
Q2 2022 Sep 06, 2022	BUY	$20.71 - $36.5 $8,760 - $15,439	423 New	423 $19,000
Q2 2022 Aug 12, 2022	SELL	$20.71 - $36.5 $8,760 - $15,439	-423 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$24.12 - $39.6 $2,966 - $4,870	123 Added 41.0%	423 $13,000
Q4 2021 Jan 12, 2022	BUY	$25.61 - $110.96 $6,402 - $27,740	250 Added 500.0%	300 $8,000
Q3 2020 Oct 29, 2020	BUY	$93.53 - $163.34 $4,676 - $8,167	50 New	50 $5,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.